CellCentric's Series B Round

CellCentric raised a round of funding on March 22, 2011.

CellCentric is a clinical stage biotechnology company focused on the development of the novel drug CCS1477 for prostate (CRPC) and other cancers.…

Articles about CellCentric's Series B Round: